We are international
• about imf TEXT SIZE   
about us    back

IMF Nurse Leadership Board (NLB) Survivorship Care Plan for Mutliple Myeloma published in the Clinical Journal of Oncology Nursing.

Patients with myeloma are surviving longer and, therefore, may experience continuing effects of their disease and treatment. Through clinical experience, the International Myeloma Foundation Nurse Leadership Board (NLB) was aware that a specific set of needs exists in this patient population. Identification of these needs, and stressing the importance of prompt intervention, could lead to improvement in their quality of life and overall survival.


Survivorship Care Guidelines for Patients Living With Multiple Myeloma
The NLB identified the most significant needs of patients diagnosed with multiple myeloma as bone health, health maintenance, mobility and safety, sexual dysfunction, and renal health. They then developed a survivorship care plan to assist healthcare providers and patients with multiple myeloma, their partners, and their caregivers to identify these needs.

Maintaining Bone Health in Patients With Multiple Myeloma
About 90% of individuals with myeloma will develop osteolytic bone lesions from increased osteoclastic and decreased osteoblastic activity. Supportive care targeting bone disease is an essential adjunct to antimyeloma therapy. In addition, the maintenance of bone health in patients with multiple myeloma can significantly improve quality of life

Routine Health Maintenance in Patients Living With Multiple Myeloma
Patients with multiple myeloma are at risk for illnesses experienced by the general population and at additional risk for illnesses related to multiple myeloma and its treatment. Therefore, the NLB has developed practice recommendations to meet the particular needs of adult patients with multiple myeloma using evidence-based recommendations for screening and disease prevention, as well as nursing experience.

Mobility and Safety in the Multiple Myeloma Survivor
Although mobility challenges vary among survivors of myeloma, patients have an increased risk of impaired mobility because of side effects of therapy and the pathology of the disease, as well as other factors (e.g., increasing age). Health maintenance increasingly is becoming a part of the cancer control continuum, and nurses have the opportunity to help survivors of multiple myeloma optimize their functional mobility and safety, thereby preserving quality of life.

Sexual Dysfunction in Multiple Myeloma
In this article, members of the NLB present evidence-based practice recommendations that have been developed for promoting dialogue and assessment, education, and management practices among patients with multiple myeloma and their healthcare providers and partners.

Renal Complications in Multiple Myeloma and Related Disorders
Kidney dysfunction is a common clinical feature of symptomatic multiple myeloma. Some degree of renal insufficiency or renal failure is present at diagnosis or will occur during the course of the disease and, if not reversed, will adversely affect overall survival and quality of life. The NLB has developed practice recommendations for screening renal function, identifying risk and environmental factors, selecting appropriate therapies and supportive care measures.

 related videos
 related articles
ASCO 2013: Dr. Jagannath - Pomalidomide (POM) with or without low-dose dexamethasone (LoDEX) in patients (Pts) with relapsed and refractory multiple myeloma (RRMM): MM-002 phase II age subgroup analysis.
"Understanding Health Disparities in Cancer: The Case of Multiple Myeloma"
Understanding Freelite and Hevylite Tests
ASCO 2013: Dr. Jagannath - Pomalidomide (POM) with or without low-dose dexamethasone (LoDEX) in patients (Pts) with relapsed and refractory multiple myeloma (RRMM): MM-002 phase II age subgroup analysis.
Best of ASH 2013: What Patients Need to Know
California Support Group Leader’s Testimony Makes Huge Difference
Cancer Awareness Bracelets
Dr. Brian Durie, Chairman of the International Myeloma Foundation, Honored by Mayo Clinic With Distinguished Alumni Award
Global Myeloma Action Network (GMAN)
IMF's 8th Annual Comedy Celebration: Big Laughs, Big Success
International Myeloma Foundation (IMF) Funds First Large-Scale Screening to Identify and Treat Precursor of Blood Cancer Before Disease Develops
International Myeloma Foundation (IMF)
Flow Workshop Presentations
July 18-19, 2014
International Myeloma Foundation Mission Statement
Mensajero del Mieloma - Otoño 2012 - #903
Michael and Robin Tuohy of Connecticut Help to Pass State Oral Parity Bill
Myeloma Minute
March 26, 2015
Pierre S. Sayad Joins IMF as Senior Vice President, Global Medical Affairs and Strategic Partnerships
Pomalidomide News: Promising Results Increase Chances of Early Drug Approval
Raise Your Voice Web Series
Sign up TODAY for Advocacy Training Two-Part Online Series!
Supreme Court Upholds Affordable Care Act
The International Myeloma Foundation Applauds Wisconsin Gov. Scott Walker for Signing SB 300 (The Cancer Treatment Fairness Act) into Law
The Military Veterans Perspective on Living with Multiple Myeloma
What does ‘dysplasia’ mean within the bone marrow report?